157 related articles for article (PubMed ID: 38069633)
21. Twelve genes at one blow: multiplex genome editing with CRISPR/Cas.
Verhage L
Plant J; 2021 Apr; 106(1):6-7. PubMed ID: 33861513
[No Abstract] [Full Text] [Related]
22. Thinking About CRISPR: The Ethics of Human Genome Editing.
Barrangou R
CRISPR J; 2019 Oct; 2(5):247-248. PubMed ID: 31599676
[No Abstract] [Full Text] [Related]
23. Engineering guide RNA to reduce the off-target effects of CRISPR.
Wu J; Yin H
J Genet Genomics; 2019 Nov; 46(11):523-529. PubMed ID: 31902584
[TBL] [Abstract][Full Text] [Related]
24. Strategies for the CRISPR-Based Therapeutics.
Li B; Niu Y; Ji W; Dong Y
Trends Pharmacol Sci; 2020 Jan; 41(1):55-65. PubMed ID: 31862124
[TBL] [Abstract][Full Text] [Related]
25. Celebrating a Decade of CRISPR-Fueled Genome Editing.
Barrangou R
CRISPR J; 2022 Jun; 5(3):354-355. PubMed ID: 35686974
[No Abstract] [Full Text] [Related]
26. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
27. Battling CRISPR-Cas9 off-target genome editing.
Li D; Zhou H; Zeng X
Cell Biol Toxicol; 2019 Oct; 35(5):403-406. PubMed ID: 31313008
[No Abstract] [Full Text] [Related]
28. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
29. Robust genome editing of CRISPR-Cas9 at NAG PAMs in rice.
Meng X; Hu X; Liu Q; Song X; Gao C; Li J; Wang K
Sci China Life Sci; 2018 Jan; 61(1):122-125. PubMed ID: 29285711
[No Abstract] [Full Text] [Related]
30. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.
Ishino Y; Krupovic M; Forterre P
J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29358495
[TBL] [Abstract][Full Text] [Related]
31. Gene editing and gene regulation with CRISPR.
Harrison P; Hart S
Exp Physiol; 2018 Apr; 103(4):437-438. PubMed ID: 29603460
[No Abstract] [Full Text] [Related]
32. Minimizing off-target effects in CRISPR-Cas9 genome editing.
Chen SJ
Cell Biol Toxicol; 2019 Oct; 35(5):399-401. PubMed ID: 31317359
[No Abstract] [Full Text] [Related]
33. Highly efficient CRISPR-mediated base editing for the gut Bacteroides spp. with pnCasBS-CBE.
Liang J; Tan Y
Biotechnol J; 2023 Jul; 18(7):e2200504. PubMed ID: 37010073
[TBL] [Abstract][Full Text] [Related]
34. CRISPR-Cpf1: A New Tool for Plant Genome Editing.
Zaidi SS; Mahfouz MM; Mansoor S
Trends Plant Sci; 2017 Jul; 22(7):550-553. PubMed ID: 28532598
[TBL] [Abstract][Full Text] [Related]
35. A toolmaker's perspective on CRISPR-directed gene editing as a therapeutic strategy for leukemia and beyond.
Kmiec EB; Bloh K
Expert Rev Hematol; 2021 Jul; 14(7):587-592. PubMed ID: 34047246
[No Abstract] [Full Text] [Related]
36. Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review).
Alagoz M; Kherad N
Int J Mol Med; 2020 Aug; 46(2):521-534. PubMed ID: 32467995
[TBL] [Abstract][Full Text] [Related]
37. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
[TBL] [Abstract][Full Text] [Related]
38. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
Liu W; Yang C; Liu Y; Jiang G
Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
[TBL] [Abstract][Full Text] [Related]
39. Review of Altered inheritance: CRISPR and the ethics of human genome editing by Françoise Baylis.
Sun BZ
Monash Bioeth Rev; 2020 May; 38(1):91-93. PubMed ID: 32314277
[No Abstract] [Full Text] [Related]
40. Nuclease-Deficient Clustered Regularly Interspaced Short Palindromic Repeat-Based Approaches for
Lek A; Ma K; Woodman KG; Lek M
Hum Gene Ther; 2021 Mar; 32(5-6):260-274. PubMed ID: 33446040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
